mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.09 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.09 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.1 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.087 |
0.1 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |